stella
beta
Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease. — Stella
Recruiting
Back to Thyroid Eye Disease trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Peking University Third Hospital, Beijing
View full record on ClinicalTrials.gov